BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int. 2012;109:477-483. [PMID: 22833761 DOI: 10.3238/arztebl.2012.0477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Shi X, Li J, Min B, Yang R, He C, Yang Y. Application of ultrasound elastography for monitoring the effects of TβR1 shRNA therapy on hepatic fibrosis in a rat model. PLoS One 2021;16:e0253150. [PMID: 34181670 DOI: 10.1371/journal.pone.0253150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Elkilany A, Fehrenbach U, Auer TA, Müller T, Schöning W, Hamm B, Geisel D. A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI. Sci Rep 2021;11:10778. [PMID: 34031487 DOI: 10.1038/s41598-021-90257-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Jain D, Torres R, Celli R, Koelmel J, Charkoftaki G, Vasiliou V. Evolution of the liver biopsy and its future. Transl Gastroenterol Hepatol 2021;6:20. [PMID: 33824924 DOI: 10.21037/tgh.2020.04.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bert F, Stahmeyer JT, Parpalea AL, Rossol S. Non-Invasive Reliable Methods to Objectify the Positive Influence of Hepatitis C Virus Treatment on Liver Stiffness. Gastroenterology Res 2021;14:31-40. [PMID: 33737997 DOI: 10.14740/gr1347] [Reference Citation Analysis]
5 Beltzer C, Quante M, Rheinberger M, Baba HA, Saner F, Fend F, Biet T, Königsrainer A, Nadalin S. [Percutaneous liver biopsy before organ removal-Impact on organ allocation and costs in liver transplantation]. Chirurg 2021;92:49-61. [PMID: 32430545 DOI: 10.1007/s00104-020-01192-w] [Reference Citation Analysis]
6 Johnson KD, Laoveeravat P, Yee EU, Perisetti A, Thandassery RB, Tharian B. Endoscopic ultrasound guided liver biopsy: Recent evidence. World J Gastrointest Endosc 2020; 12(3): 83-97 [PMID: 32218888 DOI: 10.4253/wjge.v12.i3.83] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
7 Buechter M, Kersting S, Gerken G, Kahraman A. Enzymatic liver function measured by LiMAx - a reliable diagnostic and prognostic tool in chronic liver disease. Sci Rep 2019;9:13577. [PMID: 31537822 DOI: 10.1038/s41598-019-49746-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1] [Cited by in Crossref: 126] [Cited by in F6Publishing: 99] [Article Influence: 42.0] [Reference Citation Analysis]
9 Poilil Surendran S, George Thomas R, Moon MJ, Jeong YY. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997-7006. [PMID: 29033567 DOI: 10.2147/ijn.s145951] [Cited by in Crossref: 37] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
10 Canbay A, Gerken G, Bechmann LP. [Hepatic steatosis : Differential diagnostics and current aspects]. Internist (Berl) 2016;57:879-92. [PMID: 27510334 DOI: 10.1007/s00108-016-0112-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Grambow E, Weinrich M, Zimpfer A, Kloker K, Klar E. Ectopic Spleen Tissue - an Underestimated Differential Diagnosis of a Hypervascularised Liver Tumour. Viszeralmedizin 2015;31:445-7. [PMID: 26889148 DOI: 10.1159/000442115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Feng L, Sun K, Zhang J, Feng G, Zhao Y. A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort study. BMJ Open 2015;5:e008032. [PMID: 26391629 DOI: 10.1136/bmjopen-2015-008032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
13 Weiß J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int 2014;111:447-52. [PMID: 25019921 DOI: 10.3238/arztebl.2014.0447] [Cited by in Crossref: 19] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
14 Celli R, Zhang X. Pathology of Alcoholic Liver Disease. J Clin Transl Hepatol 2014;2:103-9. [PMID: 26357621 DOI: 10.14218/JCTH.2014.00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
15 Tannapfel A. [Chronic liver diseases--new therapy. Are biopsies necessary?]. Pathologe 2013;34 Suppl 2:211-3. [PMID: 24196615 DOI: 10.1007/s00292-013-1808-8] [Reference Citation Analysis]
16 Tannapfel A, Dienes, Lohse. In reply. Dtsch Arztebl Int 2013;110:60. [PMID: 23413393 DOI: 10.3238/arztebl.2013.0060] [Reference Citation Analysis]
17 Schultze G. Thrombocyte aggregation inhibitors are important. Dtsch Arztebl Int 2013;110:59. [PMID: 23413391 DOI: 10.3238/arztebl.2013.0059a] [Reference Citation Analysis]
18 Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. [PMID: 23451000 DOI: 10.3238/arztebl.2013.0085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
19 Baierlein SA. Biopsy and puncture track metastasis. Dtsch Arztebl Int 2013;110:59. [PMID: 23413392 DOI: 10.3238/arztebl.2013.0059b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]